Search Results - "Bi, Xingang"

Refine Results
  1. 1

    Efficacy and safety of oncolytic viruses in advanced or metastatic cancer: a network meta-analysis by Xie, Ruiyang, Bi, Xingang, Shang, Bingqing, Zhou, Aiping, Shi, Hongzhe, Shou, Jianzhong

    Published in Virology journal (31-07-2021)
    “…Oncolytic viruses (OVs) have shown prospects in advanced and metastatic cancer, and many clinical trials have been carried out. To compare OV therapies…”
    Get full text
    Journal Article
  2. 2

    Long-term survival and prognostic factors for locally advanced renal cell carcinoma with renal vein tumor thrombus by Cao, Chuanzhen, Bi, Xingang, Liang, Jing, Li, Lin, Zhang, Huijuan, Xiao, Zhendong, Xiao, Zejun, Tian, Jun, Wang, Dong, Guan, Kaopeng, Li, Changling, Ma, Jianhui, Zheng, Shan, Shou, Jianzhong

    Published in BMC cancer (13-02-2019)
    “…Previous related studies have mainly focused on renal cell carcinoma (RCC) with venous tumor thrombus, specifically inferior vena cava tumor thrombus with…”
    Get full text
    Journal Article
  3. 3

    Optimizing targeted drug selection in combination therapy for patients with advanced or metastatic renal cell carcinoma: A systematic review and network meta‐analysis of safety by Xie, Ruiyang, Wu, Jie, Shang, Bingqing, Bi, Xingang, Jiang, Weixing, Cao, Chuanzhen, Zhou, Aiping, Shi, Hongzhe, Shou, Jianzhong

    Published in Cancer medicine (Malden, MA) (01-03-2023)
    “…Objective For patients with advanced or metastatic renal cell carcinoma (RCC), the dose of targeted agents was recommended in combination with immune…”
    Get full text
    Journal Article
  4. 4

    Prognostic Significance of NLR About NETosis and Lymphocytes Perturbations in Localized Renal Cell Carcinoma With Tumor Thrombus by Shang, Bingqing, Guo, Liping, Shen, Rongfang, Cao, Chuanzhen, Xie, Ruiyang, Jiang, Weixing, Wen, Li, Bi, Xingang, Shi, Hongzhe, Zheng, Shan, Li, Changling, Ma, Jianhui, Zhang, Kaitai, Feng, Lin, Shou, Jianzhong

    Published in Frontiers in oncology (21-12-2021)
    “…Non-metastatic renal cell carcinoma (RCC) with tumor thrombus showed a greater tendency for developing metastases after surgery. Early identification of…”
    Get full text
    Journal Article
  5. 5

    The C228T mutation of TERT promoter frequently occurs in bladder cancer stem cells and contributes to tumorigenesis of bladder cancer by Li, Chong, Wu, Song, Wang, Haifeng, Bi, Xingang, Yang, Zhao, Du, Ying, He, Luyun, Cai, Zhiming, Wang, Jiansong, Fan, Zusen

    Published in Oncotarget (14-08-2015)
    “…Bladder cancer is one of the most common malignant tumors worldwide. Bladder cancer stem cells (BCSCs) have been isolated recently but have not been defined…”
    Get full text
    Journal Article
  6. 6

    Neutrophil extracellular traps primed intercellular communication in cancer progression as a promising therapeutic target by Shang, Bingqing, Cui, Honglei, Xie, Ruiyang, Wu, Jie, Shi, Hongzhe, Bi, Xingang, Feng, Lin, Shou, Jianzhong

    Published in Biomarker research (02-03-2023)
    “…In addition to the anti-infection response, neutrophils are linked to tumor progression through the secretion of inflammation components and neutrophil…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Promising Immunotherapy in Metastatic Testicular Sex Cord Stromal Tumours After First-Line Chemotherapy by Shang, Bingqing, Cao, Chuanzhen, Jiang, Weixing, Shi, Hongzhe, Bi, Xingang, Cui, Chengxu, Shou, Jianzhong, Zheng, Shan, Zhang, Jin, Zhou, Aiping, Li, Changling, Ma, Jianhui

    Published in Frontiers in immunology (10-01-2022)
    “…Testicular sex cord stromal tumours (TSCSTs) are rare, with few studies focusing on the metastatic TSCST prognosis. The value of treatments, including radical…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Neutrophil extracellular traps in relationship to efficacy of systemic therapy for metastatic renal cell carcinoma by Xie, Ruiyang, Shang, Bingqing, Shi, Hongzhe, Bi, Xingang, Song, Yan, Qu, Wang, Bai, Hongsong, Hu, Linjun, Wu, Jie, Cui, Honglei, Du, Gan, Guo, Lei, Zheng, Shan, Ying, Jianming, Li, Changling, Ma, Jianhui, Zhou, Aiping, Shou, Jianzhong

    Published in Cancer medicine (Malden, MA) (01-12-2023)
    “…Background The efficacy of systemic therapy regimens, such as immune checkpoint inhibitors and tyrosine kinase inhibitors (IO‐TKI) and targeted therapy, for…”
    Get full text
    Journal Article
  12. 12

    Deaths and adverse events from adjuvant therapy with immune checkpoint inhibitors in solid malignant tumors: A systematic review and network meta‐analysis by Xie, Ruiyang, Wu, Jie, Shang, Bingqing, Bi, Xingang, Cao, Chuanzhen, Guan, Youyan, Shi, Hongzhe, Shou, Jianzhong

    Published in Cancer innovation (Print) (01-12-2022)
    “…Background By prolonging overall survival and reducing disease recurrence rates, immune checkpoint inhibitors (ICIs) are an emerging adjuvant therapy option…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Role of DNA polymerases family members in cancer: The pan-cancer perspective by Luo, Zhiwen, Bi, Xinyu, Bi, Xingang

    Published in Journal of clinical oncology (20-01-2021)
    “…Abstract only 475 Background: DNA polymerases family (DNA pols) has a lengthy reported significant influence on the initiation, development, and progress of…”
    Get full text
    Journal Article
  15. 15

    Decision tree model with tumor immune function genes for predicting response to anti-PD1 therapy in renal cell carcinoma by Bi, Xingang, Luo, Zhiwen, Bi, Xinyu

    Published in Journal of clinical oncology (20-05-2020)
    “…Abstract only e17084 Background: No current models can predict prognosis as well as immunotherapy benefits in renal cell carcinoma (RCC). The current study was…”
    Get full text
    Journal Article
  16. 16

    Targeting the deubiquitinase STAMBPL1 triggers apoptosis in prostate cancer cells by promoting XIAP degradation by Chen, Xi, Shi, Hongzhe, Bi, Xingang, Li, Yajian, Huang, Zhenhua

    Published in Cancer letters (01-08-2019)
    “…The zinc metalloprotease STAM-binding protein-like 1 (STAMBPL1) has been identified as a deubiquitinase by specifically cleaving Lys-63-linked polyubiquitin…”
    Get full text
    Journal Article
  17. 17

    Hot clear cell renal cell carcinoma immune status: Illusion or reality? by Bi, Xingang, Lu, Yi, Bi, Xinyu, Luo, Zhiwen

    Published in Journal of clinical oncology (20-05-2021)
    “…Abstract only e16575 Background: High tumor mutation burden (TMB) and increased CD8+ T cells infiltration are associated with positive ICIs response in many…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Predictive Value of Neutrophil Extracellular Traps in Neoadjuvant Chemotherapy for Muscle‐Invasive Bladder Cancer by Shang, Bingqing, Hu, Zhilong, Xie, Ruiyang, Wu, Jie, Qu, Wang, Zhang, Wen, Zhou, Aiping, Feng, Lin, Bi, Xingang, Shou, Jianzhong

    Published in Molecular carcinogenesis (14-11-2024)
    “…ABSTRACT Cisplatin‐based chemotherapy is the recommended therapy for muscle‐invasive bladder cancer (MIBC). However, the efficacy of MIBC for chemotherapy is…”
    Get full text
    Journal Article
  20. 20